Last reviewed · How we verify
Appello Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Psychiatry · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Aclaris Therapeutics, Inc. · 1 shared drug class
- Addpharma Inc. · 1 shared drug class
- Gedeon Richter Plc. · 1 shared drug class
- Geropharm · 1 shared drug class
- H. Lundbeck A/S · 1 shared drug class
- Infan Industria Quimica Farmaceutica Nacional · 1 shared drug class
- Phytopharm Consulting Brazil · 1 shared drug class
- Shire · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Appello Pharmaceuticals, Inc.:
- Appello Pharmaceuticals, Inc. pipeline updates — RSS
- Appello Pharmaceuticals, Inc. pipeline updates — Atom
- Appello Pharmaceuticals, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Appello Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/appello-pharmaceuticals-inc. Accessed 2026-06-10.